Integra LifeSciences Holdings Corporation (IART)

IART Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,643	1,611	1,542	1,558	1,542	1,372
Revenue Growth (YoY)	4.99%	4.47%	-1.03%	0.99%	12.43%	-9.60%
Cost of Revenue	698.35	651.41	593.66	587.36	597.81	520.83
Gross Profit	944.62	959.12	947.92	970.31	944.64	851.03
Selling, General & Admin	687.9	665.53	592.64	616.32	637.45	594.53
Research & Development	88.39	97.43	82.84	101.19	93.05	77.38
Amortization of Goodwill & Intangibles	14.9	14.19	12.38	13.88	14.16	27.76
Operating Expenses	791.2	777.15	687.86	731.39	744.66	699.66
Operating Income	153.42	181.98	260.06	238.92	199.98	151.37
Interest Expense	-81.57	-70.63	-51.38	-49.59	-50.4	-71.58
Interest & Investment Income	19.01	20.04	17.2	11.92	6.74	9.3
Currency Exchange Gain (Loss)	-15.27	35.23	-35.75	3.3	-	-1.6
Other Non Operating Income (Expenses)	13.98	-30.98	38.6	8.71	19.31	6.03
EBT Excluding Unusual Items	89.58	135.63	228.74	213.25	175.63	93.52
Merger & Restructuring Charges	-4.95	-4.95	-1.05	-	-	-
Impairment of Goodwill	-511.37	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	0.64	41.8	-
Asset Writedown	-4.6	-11.7	-	-	-2.75	-
Other Unusual Items	-113.94	-137.22	-146.62	-	-	-
Pretax Income	-545.27	-18.24	81.07	213.89	214.68	93.52
Income Tax Expense	-49.94	-11.29	13.33	33.34	45.6	-40.37
Earnings From Continuing Operations	-495.34	-6.94	67.74	180.55	169.08	133.89
Net Income	-495.34	-6.94	67.74	180.55	169.08	133.89
Net Income to Common	-495.34	-6.94	67.74	180.55	169.08	133.89
Net Income Growth	-	-	-62.48%	6.79%	26.28%	166.71%
Shares Outstanding (Basic)	77	77	80	83	85	85
Shares Outstanding (Diluted)	77	77	80	84	85	85
Shares Change (YoY)	-0.99%	-4.14%	-3.81%	-2.30%	0.30%	-1.46%
EPS (Basic)	-6.47	-0.09	0.85	2.18	2.00	1.58
EPS (Diluted)	-6.47	-0.09	0.84	2.16	1.98	1.57
EPS Growth	-	-	-61.11%	9.09%	26.11%	170.69%
Free Cash Flow	-4.51	24.96	73.09	222.13	264.41	164.94
Free Cash Flow Per Share	-0.06	0.32	0.91	2.66	3.09	1.94
Gross Margin	57.49%	59.55%	61.49%	62.29%	61.24%	62.03%
Operating Margin	9.34%	11.30%	16.87%	15.34%	12.96%	11.03%
Profit Margin	-30.15%	-0.43%	4.39%	11.59%	10.96%	9.76%
Free Cash Flow Margin	-0.27%	1.55%	4.74%	14.26%	17.14%	12.02%
EBITDA	311.51	322.87	383.57	357.22	319.82	267.4
EBITDA Margin	18.96%	20.05%	24.88%	22.93%	20.73%	19.49%
D&A For EBITDA	158.09	140.89	123.51	118.3	119.84	116.03
EBIT	153.42	181.98	260.06	238.92	199.98	151.37
EBIT Margin	9.34%	11.30%	16.87%	15.34%	12.96%	11.03%
Effective Tax Rate	-	-	16.44%	15.59%	21.24%	-

Updated Oct 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q